WallStreetZenWallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Stock

Open Broker Account
$12.97+0.00 (+0%)
Updated Sep 30, 2022
TAK Price
$12.97
Fair Value Price
N/A
Market Cap
$43.22B
52 Week Low
$12.75
52 Week High
$16.39
P/E
27.42x
P/B
0.92x
P/S
1.77x
PEG
0.35x
Dividend Yield
N/A
Revenue
$26.73B
Earnings
$1.45B
Gross Margin
67.7%
Operating Margin
10.97%
Profit Margin
5.5%
Debt to Equity
1.23
Operating Cash Flow
$9B
Beta
0.56
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TAK Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TAK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TAK ($12.97) is trading below its intrinsic value of $50.58, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TAK is good value based on its earnings relative to its share price (27.42x), compared to the US market average (27.64x)
P/E vs Market Valuation
TAK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more TAK due diligence checks available for Premium users.

Be the first to know about important TAK news, forecast changes, insider trades & much more!

TAK News

Valuation

TAK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
27.42x
Industry
20.18x
Market
27.64x
TAK is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TAK is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

TAK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.92x
Industry
1.68x
TAK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TAK price to earnings growth (PEG)

For valuing profitable companies with growth potential
TAK is good value based... subscribe to Premium to read more.
PEG Value Valuation

TAK's financial health

Profit margin

Revenue
$7.1B
Net Income
$771.1M
Profit Margin
10.8%
TAK's Earnings (EBIT) of $2.93B... subscribe to Premium to read more.
Interest Coverage Financials
TAK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$103.3B
Liabilities
$56.9B
Debt to equity
1.23
TAK's short-term assets ($18.97B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TAK's long-term liabilities ($41.53B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TAK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$771.6M
Investing
-$695.4M
Financing
-$1.6B
TAK's operating cash flow ($8.67B)... subscribe to Premium to read more.
Debt Coverage Financials

TAK vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
TAK$43.22B0.00%27.42x0.92x
ZTS$69.42B-1.76%33.55x15.16x
CTLT$13.02B-2.58%25.39x2.71x
VTRS$10.33B-0.93%13.52x0.52x
TEVA$8.96B+3.20%-8.49x0.99x

Takeda Pharmaceutical Co Stock FAQ

What is Takeda Pharmaceutical Co's quote symbol?

NYSE: TAK) Takeda Pharmaceutical Co trades on the NYSE under the ticker symbol TAK. Takeda Pharmaceutical Co stock quotes can also be displayed as NYSE: TAK.

If you're new to stock investing, here's how to buy Takeda Pharmaceutical Co stock.

What is the 52 week high and low for Takeda Pharmaceutical Co (NYSE: TAK)?

(NYSE: TAK) Takeda Pharmaceutical Co's 52-week high was $16.39, and its 52-week low was $12.75. It is currently -20.87% from its 52-week high and 1.73% from its 52-week low.

How much is Takeda Pharmaceutical Co stock worth today?

(NYSE: TAK) Takeda Pharmaceutical Co currently has 1,666,098,437 outstanding shares. With Takeda Pharmaceutical Co stock trading at $12.97 per share, the total value of Takeda Pharmaceutical Co stock (market capitalization) is $43.22B.

Takeda Pharmaceutical Co stock was originally listed at a price of $21.37 in Jan 5, 2010. If you had invested in Takeda Pharmaceutical Co stock at $21.37, your return over the last 12 years would have been -39.31%, for an annualized return of -4.08% (not including any dividends or dividend reinvestments).

How much is Takeda Pharmaceutical Co's stock price per share?

(NYSE: TAK) Takeda Pharmaceutical Co stock price per share is $12.97 today (as of Sep 30, 2022).

What is Takeda Pharmaceutical Co's Market Cap?

(NYSE: TAK) Takeda Pharmaceutical Co's market cap is $43.22B, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Takeda Pharmaceutical Co's market cap is calculated by multiplying TAK's current stock price of $12.97 by TAK's total outstanding shares of 1,666,098,437.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.